The Royal Marsden Cancer Charity has appointed its trustee Douglas Flint to chair its board.
Flint, who has been on the board of the London cancer specialist hospital’s charity since 2017, will also chair the Royal Marsden NHS Foundation Trust.
He succeeds Charles Alexander in December, when his six-year term as chair comes to an end.
During his career in the financial sector Flint held senior roles at HSBC for more than two decades, including stints as its group finance director and group chairman.
He received a knighthood in 2018 for services to the financial sector and is also a former partner at accountancy firm KPMG.
"I am proud of my involvement with The Royal Marsden Cancer Charity, and through this I have learned a great deal about the work of the hospital and its extraordinary staff,” said Flint.
“I have found the experience both humbling and inspiring; the commitment to excellence, the empathy for those who enter their care, the pride at all levels in the hospital in what they do and the understated, yet real, contribution that is being made to fundamental research and clinical excellence for the benefit of current and future generations.”
Royal Marsden Cancer Charity managing director Antonia Dalmahoy added: “Douglas’s breadth of business experience and his passion for The Royal Marsden and The Royal Marsden Cancer Charity will be of immense value to all of us.”
Recent Stories